# Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy

> **NCT05358652** · — · UNKNOWN · sponsor: **Fundacin Biomedica Galicia Sur** · enrollment: 60 (estimated)

## Conditions studied

- Lupus Nephritis
- Systemic Lupus Erythematosus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05358652
- **Lead sponsor:** Fundacin Biomedica Galicia Sur
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-15
- **Primary completion:** 2022-07-15
- **Final completion:** 2023-01-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-05-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05358652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05358652, "Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05358652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*